Feature | HRS | May 15, 2019 | Dave Fornell, Editor

Heart Rhythm Society 2019 Late-Breaking Clinical Trials

HRS late-breaker studies will highlight the biggest news in electrophysiology

HRS 2019 late breaking trials, late breaking presentations for the biggest news in electrophysiology (EP). #HRS #HRS2019 #HRS19

May 15, 2019 — The Heart Rhythm Society (HRS) had 21 late-breaking study presentations at the 2019 Heart Rhythm Scientific Sessions. Here is a completed list of the studies presented with links to more information. This includes the latest in clinical research, techniques and technologies in cardiac electrophysiology (EP). For more details on HRS 2019, visit www.hrssessions.org.


Late Breaking Clinical Trials Session I
Thursday, May 9, 8 – 9:30 a.m.
   • Transcutaneous Electrical Vagus Nerve Stimulation To Suppress Atrial Fibrillation (TREAT AF): A Randomized Clinical Trial 

   • Prospective Randomized Comparison Of Rotor Ablation vs. Conventional Ablation For Treatment Of Persistent Atrial Fibrillation - The REAFFIRM Trial 

   • Evaluate Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibillation (ERADICATE-AF) Trial  

   • Baroreflex Activation Therapy In Patients With Heart Failure With A Reduced Ejection Fraction  

   • His Corrective Pacing Or Bi-ventricular Pacing For Cardiac Resynchronization In Heart Failure: A Randomized Pilot Trial (HIS SYNC)


Late Breaking Clinical Trials Session II: New Data for Device Therapies
Friday, May 10, 1:30 – 3 p.m.
   • Update From The Prevention Of Arrhythmia Device Infection Trial (PADIT); Development Of The PADIT Infection Risk Score 

   • Decline In Ventricular Arrhythmia Events And Mortality In The Multicenter Automatic Defibrillator Implantation Trials  

   • After RAFT: Long Term Outcomes Of Cardiac Resynchronization Therapy  

   • Cardiac Resynchronization Therapy In Chemotherapy-induced Cardiomyopathy: Results Of The Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-induced Cardiomyopathy (MADIT-CHIC) Study

   • Understanding Outcomes With The S-ICD In Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Study: High Conversion Efficacy And Low Adverse Event Rate During The First 30 Days 


Late Breaking Clinical Trials Session III: Late-Breaking Science
Friday, May 10, 4:30 – 6 p.m.
   • Prospective Evaluation Of Feasibility, Electrophysiological And Echocardiographic Characteristics Of Left Bundle Branch Area Pacing 

   • Is Nonselective His Bundle Pacing Good Enough? Long-term Outcomes From The Geisinger-Rush HBP Registry

   • Preventive Ablation Of Ventricular Tachycardia In Patients With Myocardial Infarction: The BERLIN-VT Trial

   • Five-year Outcomes In Cardiac Surgery Patients With Atrial Fibrillation Undergoing Concomitant Surgical Ablation Versus No Ablation. The Long-term Follow-up of the Prague-12 Study  

   • Real-time Electrogram Analysis For Drivers Of Atrial Fibrillation (Radar): A Multi-center, FDA-IDE, Clinical Trial Of Persistent AF

   • Pulsed Field Ablation For Pulmonary Vein Isolation: Lesion Durability And Chronic Safety  


Late Breaking Clinical Trials Session IV: Innovations
Saturday, May 11, 10:30 a.m. - Noon 
   • First-in-human Chronic Implant Experience Of The Medtronic Substernal Extravascular Implantable Cardioverter Defibrillator

   • DIGITAL-AF II: Results From A Real-life Digital Atrial Fibrillation Screening Using Smartphones And Outcome Registry In The General Population

   • Non-invasive Localization Of Cardiac Arrhythmias Using Electromechanical Wave Ultrasound Imaging

   • A Novel Percutaneous Carotid Coil Filter For Stroke Prevention In Atrial Fibrillation: Outcomes Of The First-in-human CAPTURE Trial

   • Bipolar Catheter Ablation For The Treatment Of Refractory Scar-related Ventricular Tachycardia: A Multicenter, Prospective FDA IDE Study



Other HRS 2019 News:

Survey Shows Big Need for Patient Education on Their Implantable Electrophysiology Devices

Airport Security Body Scanners Do Not Interfere With Pacemakers, ICDs 

Studies Find Race and Gender Disparities in Implantable Heart Devices

HRS Releases New Expert Consensus Statement on Arrhythmogenic Cardiomyopathy


New Global Consensus Statement Addresses Catheter Ablation of Ventricular Arrhythmias

VIDEO: Use of an Antibacterial Envelope to Reduce Infections for Pacemakers, ICDs — Interview with Khaldoun Tarakji, M.D.

VIDEO: Key Trends in Electrophysiology — Apple Watch to Detect AF and the CABANA Trial — Interview with Christine Albert, M.D.,

Find links to other Heart Rhythm Scientific Sessions news



Industry News at HRS 2019:

Philips and Medtronic Collaborate on Image-guided Atrial Fibrillation Treatment

Abbott Launches Next-generation Confirm RX Implantable Cardiac Monitor

FDA Approves Attain Stability Quad MRI SureScan Lead from Medtronic

Biosense Webster Launches Cartonet Analytics Software for Electrophysiology


Murj Launches Murj 2.0 Implantable Cardiac Device Management Software

Acutus Medical Receives FDA Clearance for Second-generation AcQMap Platform

CardioFocus Announces European CE Mark Approval Of HeartLight X3 System

Biocardia Receives FDA Clearance for Avance Steerable Introducer Family


Spacelabs Debuts Sentinel 11 Cardiology Information Management System

Stereotaxis Announces Next-generation Robotic Magnetic Navigation and Imaging Systems

Preventice Solutions Presents Real-World Performance Data on BodyGuardian Remote Monitoring System With AI

CardioFocus Announces Results From HeartLight X3 Ablation System Pivotal Study


Related Content

News | Atrial Fibrillation

December 14, 2022 — Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of ...

Home December 14, 2022
News | Atrial Fibrillation

November 10, 2022 — Biosense Webster, Inc., the global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home November 10, 2022
News | Atrial Fibrillation

November 10, 2022 — A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding ...

Home November 10, 2022
News | Atrial Fibrillation

October 31, 2022 — Atrial fibrillation – a form of irregular heartbeat, or arrhythmia – leads to more than 454,000 ...

Home October 31, 2022
News | Atrial Fibrillation

October 26, 2022 — A new study from University of Louisville researchers in the Christina Lee Brown Envirome Institute ...

Home October 26, 2022
News | Atrial Fibrillation

September 14, 2022 — In recognition of Atrial Fibrillation (AFib) Awareness Month, Biosense Webster, Inc., part of ...

Home September 14, 2022
News | Atrial Fibrillation

September 9, 2 022 — A large-scale international study led by Mount Sinai has yielded the first risk score that can help ...

Home September 09, 2022
News | Atrial Fibrillation

August 31, 2022 — Science has long shown that men are at greater risk for developing atrial fibrillation (AFib) than ...

Home August 31, 2022
News | Atrial Fibrillation

July 29, 2022 — A cohort study of persons with incident atrial fibrillation (AF) has found that AF after noncardiac ...

Home July 29, 2022
News | Atrial Fibrillation

July 20, 2022 — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial ...

Home July 20, 2022
Subscribe Now